116 related articles for article (PubMed ID: 1706600)
1. Transplacentally-transported 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects the catecholamine and indoleamine levels in the fetal mouse brain.
Ohya Y; Naoi M; Ochi N; Mizutani N; Watanabe K; Nagatsu T
J Neural Transm Park Dis Dement Sect; 1990; 2(4):277-83. PubMed ID: 1706600
[TBL] [Abstract][Full Text] [Related]
2. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
[TBL] [Abstract][Full Text] [Related]
4. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
[TBL] [Abstract][Full Text] [Related]
5. Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
Sai T; Uchida K; Nakayama H
J Toxicol Sci; 2013; 38(3):445-58. PubMed ID: 23665943
[TBL] [Abstract][Full Text] [Related]
6. Uptake of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the N-methyl-4-phenylpyridinium ion (MPP+) into fetal mouse brain through the placenta.
Ohya Y; Naoi M; Ochi N; Mizutani N; Watanabe K; Nagatsu T
Neurosci Lett; 1989 Oct; 105(1-2):221-6. PubMed ID: 2485882
[TBL] [Abstract][Full Text] [Related]
7. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
[TBL] [Abstract][Full Text] [Related]
8. The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
Bonuccelli U; Garant D; Fariello R
Neurosci Lett; 1991 Mar; 124(1):22-6. PubMed ID: 1713316
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of dopamine and its metabolites, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in brain tissue using liquid chromatography and electrochemical detection.
Lyness WH
Life Sci; 1982 Oct; 31(14):1435-43. PubMed ID: 6183552
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice.
Saitoh T; Niijima K; Mizuno Y
J Neurol Sci; 1987 Feb; 77(2-3):229-35. PubMed ID: 3493330
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
Pileblad E; Nissbrandt H; Carlsson A
J Neural Transm; 1984; 60(3-4):199-203. PubMed ID: 6084705
[TBL] [Abstract][Full Text] [Related]
12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.
Corsini GU; Zuddas A; Bonuccelli U; Schinelli S; Kopin IJ
Life Sci; 1987 Mar; 40(9):827-32. PubMed ID: 2434820
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.
Chiueh CC; Markey SP; Burns RS; Johannessen JN; Pert A; Kopin IJ
Eur J Pharmacol; 1984 Apr; 100(2):189-94. PubMed ID: 6203759
[TBL] [Abstract][Full Text] [Related]
14. Dopamine, serotonin, and acid metabolites in brain regions from the developing offspring of ethanol-treated rats.
Rathbun W; Druse MJ
J Neurochem; 1985 Jan; 44(1):57-62. PubMed ID: 2578063
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
16. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
Johannessen JN; Sobotka TJ; Weise VK; Markey SP
J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice.
Cheng FC; Ni DR; Wu MC; Kuo JS; Chia LG
Neurosci Lett; 1998 Aug; 252(2):87-90. PubMed ID: 9756328
[TBL] [Abstract][Full Text] [Related]
19. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
Andrews AM; Murphy DL
J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats.
Heikkila RE; Nicklas WJ; Duvoisin RC
Neurosci Lett; 1985 Aug; 59(1):135-40. PubMed ID: 2413402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
